UniProt ID | RTCA_HUMAN | |
---|---|---|
UniProt AC | O00442 | |
Protein Name | RNA 3'-terminal phosphate cyclase | |
Gene Name | RTCA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 366 | |
Subcellular Localization | Nucleus, nucleoplasm. | |
Protein Description | Catalyzes the conversion of 3'-phosphate to a 2',3'-cyclic phosphodiester at the end of RNA. The mechanism of action of the enzyme occurs in 3 steps: (A) adenylation of the enzyme by ATP; (B) transfer of adenylate to an RNA-N3'P to produce RNA-N3'PP5'A; (C) and attack of the adjacent 2'-hydroxyl on the 3'-phosphorus in the diester linkage to produce the cyclic end product. The biological role of this enzyme is unknown but it is likely to function in some aspects of cellular RNA processing.. | |
Protein Sequence | MAGPRVEVDGSIMEGGGQILRVSTALSCLLGLPLRVQKIRAGRSTPGLRPQHLSGLEMIRDLCDGQLEGAEIGSTEITFTPEKIKGGIHTADTKTAGSVCLLMQVSMPCVLFAASPSELHLKGGTNAEMAPQIDYTVMVFKPIVEKFGFIFNCDIKTRGYYPKGGGEVIVRMSPVKQLNPINLTERGCVTKIYGRAFVAGVLPFKVAKDMAAAAVRCIRKEIRDLYVNIQPVQEPKDQAFGNGNGIIIIAETSTGCLFAGSSLGKRGVNADKVGIEAAEMLLANLRHGGTVDEYLQDQLIVFMALANGVSRIKTGPVTLHTQTAIHFAEQIAKAKFIVKKSEDEEDAAKDTYIIECQGIGMTNPNL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
27 | Phosphorylation | LRVSTALSCLLGLPL EEHHHHHHHHHCCCC | 10.56 | - | |
28 | Ubiquitination | RVSTALSCLLGLPLR EHHHHHHHHHCCCCE | 3.65 | 27667366 | |
44 | Phosphorylation | QKIRAGRSTPGLRPQ EEHHCCCCCCCCCHH | 37.73 | 28857561 | |
45 | Phosphorylation | KIRAGRSTPGLRPQH EHHCCCCCCCCCHHH | 21.73 | 28857561 | |
49 (in isoform 2) | Phosphorylation | - | 34.45 | - | |
50 (in isoform 2) | Phosphorylation | - | 30.87 | - | |
85 | Ubiquitination | TFTPEKIKGGIHTAD EECHHHCCCCCCCCC | 63.25 | 27667366 | |
98 | Ubiquitination | ADTKTAGSVCLLMQV CCCCCCHHHHHHEEE | 13.75 | 27667366 | |
99 | Ubiquitination | DTKTAGSVCLLMQVS CCCCCHHHHHHEEEC | 2.33 | 21963094 | |
106 | Ubiquitination | VCLLMQVSMPCVLFA HHHHEEECCCEEEEE | 10.50 | 21890473 | |
141 | Ubiquitination | DYTVMVFKPIVEKFG CEEEEEEHHHHHHHC | 23.56 | - | |
154 (in isoform 2) | Ubiquitination | - | 46.66 | - | |
156 | Acetylation | FIFNCDIKTRGYYPK EEEECEECCCCCCCC | 20.93 | 26051181 | |
156 | Ubiquitination | FIFNCDIKTRGYYPK EEEECEECCCCCCCC | 20.93 | 21963094 | |
160 | Phosphorylation | CDIKTRGYYPKGGGE CEECCCCCCCCCCCE | 17.19 | 28102081 | |
161 | Phosphorylation | DIKTRGYYPKGGGEV EECCCCCCCCCCCEE | 10.99 | 28102081 | |
163 (in isoform 1) | Ubiquitination | - | 54.81 | 21890473 | |
163 | Acetylation | KTRGYYPKGGGEVIV CCCCCCCCCCCEEEE | 54.81 | 23954790 | |
163 | Ubiquitination | KTRGYYPKGGGEVIV CCCCCCCCCCCEEEE | 54.81 | 21890473 | |
163 | Ubiquitination | KTRGYYPKGGGEVIV CCCCCCCCCCCEEEE | 54.81 | 27667366 | |
163 | Malonylation | KTRGYYPKGGGEVIV CCCCCCCCCCCEEEE | 54.81 | 26320211 | |
169 (in isoform 2) | Ubiquitination | - | 1.10 | - | |
169 | Ubiquitination | PKGGGEVIVRMSPVK CCCCCEEEEECCCCC | 1.10 | 21963094 | |
173 | Phosphorylation | GEVIVRMSPVKQLNP CEEEEECCCCCCCCC | 18.90 | 25159151 | |
176 | Ubiquitination | IVRMSPVKQLNPINL EEECCCCCCCCCCCC | 53.07 | 27667366 | |
176 | Ubiquitination | IVRMSPVKQLNPINL EEECCCCCCCCCCCC | 53.07 | 21890473 | |
176 (in isoform 2) | Ubiquitination | - | 53.07 | 21890473 | |
184 | Phosphorylation | QLNPINLTERGCVTK CCCCCCCCCCCCEEE | 21.10 | 20068231 | |
189 | Ubiquitination | NLTERGCVTKIYGRA CCCCCCCEEEEECCH | 7.32 | 29967540 | |
189 (in isoform 2) | Ubiquitination | - | 7.32 | - | |
191 | Acetylation | TERGCVTKIYGRAFV CCCCCEEEEECCHHH | 17.34 | 25953088 | |
191 | Ubiquitination | TERGCVTKIYGRAFV CCCCCEEEEECCHHH | 17.34 | - | |
204 (in isoform 2) | Ubiquitination | - | 9.69 | - | |
205 | Methylation | VAGVLPFKVAKDMAA HEECCCHHHHHHHHH | 39.07 | 115977427 | |
205 | Acetylation | VAGVLPFKVAKDMAA HEECCCHHHHHHHHH | 39.07 | 25953088 | |
208 | Malonylation | VLPFKVAKDMAAAAV CCCHHHHHHHHHHHH | 51.53 | 26320211 | |
208 | Ubiquitination | VLPFKVAKDMAAAAV CCCHHHHHHHHHHHH | 51.53 | 29967540 | |
210 | Sulfoxidation | PFKVAKDMAAAAVRC CHHHHHHHHHHHHHH | 2.42 | 30846556 | |
221 (in isoform 2) | Ubiquitination | - | 33.15 | - | |
221 | Ubiquitination | AVRCIRKEIRDLYVN HHHHHHHHHHHHCCC | 33.15 | 29967540 | |
272 | Ubiquitination | KRGVNADKVGIEAAE HCCCCHHHHHHHHHH | 39.69 | - | |
285 (in isoform 2) | Ubiquitination | - | 3.39 | - | |
314 | Phosphorylation | NGVSRIKTGPVTLHT CCCCEEECCCEEEEH | 44.33 | 29255136 | |
318 | Phosphorylation | RIKTGPVTLHTQTAI EEECCCEEEEHHHHH | 18.89 | 29255136 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RTCA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RTCA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RTCA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RL21_HUMAN | RPL21 | physical | 17353931 | |
FBRL_HUMAN | FBL | physical | 17353931 | |
RL23A_HUMAN | RPL23A | physical | 17353931 | |
RL18A_HUMAN | RPL18A | physical | 17353931 | |
DDX21_HUMAN | DDX21 | physical | 17353931 | |
ZCCHV_HUMAN | ZC3HAV1 | physical | 22939629 | |
HNRH1_HUMAN | HNRNPH1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...